Safety profile during initiation of propranolol for treatment of infantile haemangiomas in an ambulatory day‐care hospitalization setting

Background Propranolol is the mainstay of treatment for infantile haemangioma. Despite its good safety profile, it is not risk‐free. Guidelines for propranolol initiation and monitoring have been suggested, but protocols vary among practitioners. Objective This study sought to assess the prevalence...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2018-11, Vol.32 (11), p.2004-2009
Hauptverfasser:	Fogel, I., Ollech, A., Zvulunov, A., Valdman‐Greenshpon, Y., Atar Snir, V., Friedland, R., Lapidoth, M., Ben‐Amitai, D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Ambulatory Care - methods Analysis of Variance Child, Preschool Cohort Studies Dose-Response Relationship, Drug Drug Administration Schedule Echocardiography - methods Electrocardiography - methods Female Hemangioma, Capillary - diagnosis Hemangioma, Capillary - drug therapy Humans Infant Injections, Subcutaneous Male Monitoring, Physiologic Neoplastic Syndromes, Hereditary - diagnosis Neoplastic Syndromes, Hereditary - drug therapy Patient Safety Propranolol - therapeutic use Retrospective Studies Risk Assessment Severity of Illness Index Skin Neoplasms - diagnosis Skin Neoplasms - drug therapy Tertiary Care Centers Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!